Recruitment for a clinical trial investigating a treatment for the rare disease #XLHED is now ongoing in 6 countries—UK, Germany, France, Italy, Spain & USA! Women in any country who are XLHED carriers and #pregnant with a boy may be able to join.
#EDELIFEclinicaltrial
@matile_group@UniGe_OrgChem@sciences_UNIGE@unige_en My father was passionate about unveiling the beauty of nature through his work. A big thanks to all of you who have collaborated with him over the years and contributed to bringing him fulfillment and joy🙏🏼
Let's raise awareness! For every visitor to Connect In Pharma on 14 & 15 September, five Swiss francs will be donated to the EspeRare Foundation.
Support us by registering for Connect in Pharma here: https://t.co/bje2cjN0uB
#raredisease#raiseawareness#communityinvolvement
The NFED is committed to supporting the EspeRare Foundation and its new partner, the @pierrefabregroup, as they develop ER-004 as a prenatal treatment for x-linked hypohidrotic ectodermal dysplasia. #XLHED#research https://t.co/lqXhDDxFHK
Excellent review of the potential for transforming human health by decoding the human immune system, authored by @HumanVacProject Scientific Steering Committee member Prof. Bali Pulendran & Prof. Mark Davis of @StanfordMed: https://t.co/Lsz5PsHlmF
@JAltheimer @ArtifactsHub How do you know it is made by Yoshindo Y? BTW he is an extraordinary men I had the honor to visit in his home/forge in the suburbs of Tokyo